Table.
Baseline characteristics
Attendees (n=3917) | Non-attendees (n=1947) | ||
---|---|---|---|
Age | 28 (24–35) | 28 (24–35) | |
Sex | |||
Female, | 2312 (59·0%) | 1137 (58·4) | |
Male | 1605 (41·0%) | 810 (41·6%) | |
Declared COVID-19 history | 681 (17·4%) | 343 (17·6%) | |
Vaccinated | |||
No | 1943 (49·6%) | 970 (49·8%) | |
One dose | 1684 (43·0%) | 844 (43·3%) | |
Two doses | 290 (7·4%) | 133 (6·8%) | |
Inclusion-to-first-dose interval, days | 14 (8–26) | 14 (7–25) | |
Inclusion-to-second-dose interval, days | 26 (15–42) | 27 (17–56) |
Data are n (%) or median IQR.